Akknatek
Kaiserslautern
About Akknatek
Akknatek is a patented technology that is included in the lens reviewer with the intention of enhancing patients' visual outcomes, particularly with IOLs, and encouraging IOL implantations in clinics. The lens reviewer decides how to treat an intraocular lens that has dislocated after surgery. It lessens the possibility of unexpected post-operative refractive complications following cataract surgery and can further reduce the necessity for subsequent refractive procedures.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.3M
- Funding stage: Seed
- Last round: Seed (Dec 2022)
- Website: akknatek.com#
- Phone: [email protected]
Industries & Categories
Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/akknatek-70912 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.